Personal information

No personal information available

Activities

Employment (1)

Weill Cornell Medicine: New York, US

Fellow (Hematology and Medical Oncology)
Employment
Source: Self-asserted source
Evelyn Orlando

Funding (1)

Preemptive Rituximab for the Prevention of PTLD in EBV-Positive Solid Organ Transplant Recipients

2025-04-01 to 2027-10-31 | Grant
Lymphoma Research Foundation (New York, US)
GRANT_NUMBER:

1374480

Source: check_circle
ProposalCentral

Works (4)

Retrospective Evaluation of R-EPOCH in the Frontline Treatment of Adult PTLD Patients Following Solid Organ Transplant

Blood Neoplasia
2025-03 | Journal article
Contributors: Brian Cuzzo; Maegan Ford; Saagar Jain; Hua-Jay Cherng; Evelyn Orlando; Patrick Gould; Amy Song; Benjamin May; Yuxuan Chen; Govind Bhagat et al.
Source: check_circle
Crossref

EBV Reactivation and Lymphomagenesis: More Questions than Answers.

Current hematologic malignancy reports
2023-08-11 | Journal article
Contributors: Ford M; Orlando E; Amengual JE
Source: Self-asserted source
Evelyn Orlando

Pilot Trial of Homebound Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy
2022-12 | Journal article
Contributors: Heather J. Landau; Evelyn Orlando; Elizabeth S. Rodriguez; Allison Applebaum; Hannah-Rose Mitchell; Jonathan U. Peled; Niloufer Khan; Tyler Funnell; David Chung; Michael Scordo et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
2015-08-30 | Journal article
Contributors: Smith E; Devlin SM; Kosuri S; Orlando E; Landau H; Alexander Lesokhin; David Chung; Hassoun H; Lendvai N; Landgren O et al.
Source: Self-asserted source
Evelyn Orlando